Wire Stories
-
539Zai Lab Announces Positive Topline Results from Phase 3 PRIME Study of ZEJULA� (Niraparib) as First-Line Monotherapy Maintenance Treatment in Chinese Women with Platinum-Responsive Advanced Ovarian Cancer
�� �PRIME�study demonstrates that�niraparib treatment had a clinically meaningful and statistically significant benefit in improving progression-free survival in the overall study population...
-
636Tier-1 US Global Military Terminal Provider Places Order of Over $5M with Gilat for Solid State Amplifiers
PETAH TIKVA, Israel, Nov. 30, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite...
-
584Albion Enterprise VCT PLC: Half-yearly Financial Report
Albion Enterprise VCT PLC LEI Code 213800OVSRDHRJBMO720 As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rule 4.2, Albion Enterprise...
-
663CTO Realty Growth Declares Quarterly Dividends for the Fourth Quarter 2021
DAYTONA BEACH, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the �Company� or �CTO�) announced today that...
-
551Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of Concern
GURUGRAM, India–(BUSINESS WIRE)–#COVID19–Premas Biotech (https://www.premasbiotech.com/) announced today that its joint venture Oravax will initiate testing of their oral virus-like particle (VLP) vaccine...
-
588
Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research
Exclusive deal for cutting-edge RNA technology in drug discovery and vaccines SYDNEY–(BUSINESS WIRE)–#Veyonda–Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel...
-
537
LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
GUANGZHOU, China–(BUSINESS WIRE)–LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for...
-
650Albion Venture Capital Trust PLC: Half-yearly Financial Report
Albion Venture Capital Trust PLC LEI Code: 213800JKELS32V2OK421 As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rule 4.2, Albion...
-
718Voltus, Inc. � The Leading Distributed Energy Resource Software Technology Platform � to Combine with Broadscale Acquisition Corp., Creating the First Public Pure-Play Company in the Industry
Voltus is the leading software technology platform monetizing distributed energy resources (DERs) � including demand response, distributed generation (e.g., solar), energy storage,...
-
538Radware and CHT Security Team Up to Protect NCSoft Taiwan�s Product Launch During Massive DDoS Attacks
Mitigate attacks and ensure successful product rollout MAHWAH, N.J., Dec. 01, 2021 (GLOBE NEWSWIRE) — Radware� (NASDAQ: RDWR), a leading provider of...
